F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$68.04M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	2.36M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	285
Open	28.01
Previous Close	28.85
Day's Range	28.01 - 28.04
52-Week Low	18.78
52-Week High	29.30
Beta	n/a
Holdings	37
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

48.41% of assets

Name	Symbol	Weight
LivaNova PLC	LIVN	6.71%
Travere Therapeutics, Inc.	TVTX	6.22%
Soleno Therapeutics, Inc.	SLNO	5.74%
RadNet, Inc.	RDNT	4.93%
KalVista Pharmaceuticals, Inc.	KALV	4.56%
TransMedics Group, Inc.	TMDX	4.49%
Madrigal Pharmaceuticals, Inc.	MDGL	4.16%
Merit Medical Systems, Inc.	MMSI	3.93%
BridgeBio Pharma, Inc.	BBIO	3.87%
Nektar Therapeutics	NKTR	3.79%